DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

References

Yazbeck R, Howarth GS, Abbott CA.
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?.

Trends Pharmacol Sci 2009;
30: 600-607
10.1016/j.tips.2009.08.003

Download Bibliographical Data

Access:
Access: